Form D · Other Technology
Reperio Health, Inc.
Portland, OR · CIK 0001826782
Offering snapshot reported Dec 27, 2024 · SEC filing
- Reported sold
- $5.12M Offering amount: $8.5M
- Investors reported
- 14 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- May 23, 2024 As reported in this filing
Fundraising history
Reported soldDates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.
What changed?
Latest filing versus its linked predecessor, where available.
- Reported sold$1,000,000 → $5,120,000
- Reported investors1 → 14
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Dec 27, 2024 | Amendment | $5,120,000 | $4,120,000vs Jul 2, 2024 | 14 | SEC filing |
| Jul 2, 2024 | Initial | $1,000,000 | No comparison | 1 | SEC filing |
| Apr 9, 2024 | Initial | $1,575,000 | No comparison | 9 | SEC filing |
| Nov 9, 2023 | Initial | $500,000 | No comparison | 1 | SEC filing |
| Sep 8, 2023 | Amendment | $8,200,000 | $6,570,000vs Jan 7, 2022 | 40 | SEC filing |
| May 23, 2023 | Initial | $2,000,000 | No comparison | 2 | SEC filing |
| Jan 7, 2022 | Initial | $1,630,000 | No comparison | 10 | SEC filing |
| Mar 17, 2021 | Amendment | $6,022,064 | $3,173,064vs Oct 15, 2020 | 18 | SEC filing |
| Oct 15, 2020 | Initial | $2,849,000 | No comparison | 10 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-517585
Source: Form D, filed Dec 27, 2024. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Tory Adams | Executive |
| Justin Autrey | Executive |
| Ildiko Crist | Executive |
| Elizabeth Curtis | Executive |
| Philip Hertik | Director |
| Charles Jewell | Executive |
| Travis Rush | Director, Executive |
| Matthew Wallington | Director, Executive |
Issuer details
Industry: Other Technology (See others in industry)
Address:
4784 Se 17 Th Ave, Suite 120
Portland, OR, 97202
Portland, OR, 97202